| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.49 | 0.006 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.46 | 0.006 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.43 | 0.008 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.009 |